Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LRRFIP2 pseudogene 1 (LRRFIP2P1) is a **pseudogene**, meaning it is a genomic DNA sequence resembling a functional gene but is generally noncoding and considered nonfunctional. It shares sequence similarity with the active LRRFIP2 gene (leucine rich repeat flightless-interacting protein 2), but unlike the parent gene, LRRFIP2P1 does not encode a protein product, nor is there any evidence supporting a role as a therapeutic target or involvement in biological functions or diseases. As such, LRRFIP2P1 is not considered a valid biological or pharmacological target, and there are no known drugs, mechanisms of action, or disease associations connected to it[4]. **Key clarification:** - LRRFIP2P1 is **not a protein, receptor, or enzyme**, and it lacks functional activity. - The active, protein-coding gene in this family is **LRRFIP2** (not LRRFIP2P1), which has biological roles, but the pseudogene LRRFIP2P1 does not[4]. - The entry is suitable for cataloguing pseudogenes but is *not* a valid therapeutic or biological target[4]. If you require data on the functional parent gene **LRRFIP2**, please specify.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LRRFIP2 pseudogene 1 (LRRFIP2P1).